the New England Journal of Medicine

Pfizer Vaccine Protects Against U.K., South Africa Variants of Coronavirus

March 2, 2021 Sector.Africa Administrator501.V2 variant, antibodies, BIONTECH, Clinical trials, COVID-19, Health sciences, Medical research, moderna, New England Journal, Pfizer, RNA vaccines, South Africa, the New England Journal, the New England Journal of Medicine, University of Texas Medical Branch0 comment

the staff of the Ridgewood blog Ridgewood NJ, the COVID19 vaccine developed by Pfizer appears to be effective against the more transmissible variants of the coronavirus, including the one first discovered in South Africa, according to a new report in the New England Journal of Medicine. Researchers at Pfizer and the University of Texas Medical Branch genetically engineered versions of COVID-19 to carry some of the mutations found in the variant discovered in South Africa and tested them against blood samples taken from 15 people who had received both doses…

COVID-19 can survive on the soles of shoes for up to five days

March 27, 2020February 18, 2021 Sector.Africa Administratoralcohol solutions, Australia, Carole Winner, Daily Mail, environmental scientist, healthcare workers, huffington post, Kansas City, Mary E. Schmidt, MELBOURNE, Missouri, New England Journal, Nicole Bijlsma, public health specialist, South Wales, stainless steel, Sydney International Airport, the New England Journal of Medicine, Timothy Newsome, University of Sydney0 comment

Infectious disease specialists have warned that COVID-19 can live on the soles of shoes for up to five days, with footwear more likely to carry coronavirus if it has been worn in busy areas like supermarkets, airports or on public transport. The sole of a shoe is the main breeding ground for bacteria, fungi and viruses, but respiratory droplets carried in the air from a person infected with coronavirus can still land anywhere on the upper part of a shoe like the laces or the heel. Soles are typically made…